These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1290920)

  • 1. A comparison of the effects of the selective peripheral alpha 1-blocker terazosin with the selective beta 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to-moderate essential hypertension.
    Ligueros M; Unwin R; Wilkins MR; Humphreys J; Coles SJ; Cleland J
    Clin Auton Res; 1992 Dec; 2(6):373-81. PubMed ID: 1290920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
    Bur A; Woisetschläger C; Herkner H; Derhaschnig U; Quehenberger P; Hirschl MM
    Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B; Guy S; Humphreys JE
    J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant administration of terazosin and atenolol for the treatment of essential hypertension.
    Holtzman JL; Kaihlanen PM; Rider JA; Lewin AJ; Spindler JS; Oberlin JA
    Arch Intern Med; 1988 Mar; 148(3):539-43. PubMed ID: 3277569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of terazosin on serum lipids.
    Deger G
    Am J Med; 1986 May; 80(5B):82-5. PubMed ID: 2872813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
    Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
    Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forearm and finger hemodynamics, blood pressure control, and lipid changes in patients with diabetic hypertension treated with atenolol and prazosin.
    Kwan CM; Shepherd AM; Johnson J; Taylor WF
    Clin Pharmacol Ther; 1988 Aug; 44(2):202-10. PubMed ID: 3293875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terazosin: a new antihypertensive agent with favorable effects on lipids.
    Luther RR
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prazosin, atenolol, and thiazide diuretic on plasma lipids in patients with essential hypertension.
    Neusy AJ; Lowenstein J
    Am J Med; 1986 Feb; 80(2A):94-9. PubMed ID: 3511694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
    Frick MH; Cox DA; Himanen P; Huttunen M; Pitkäjärvi T; Pörsti P; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
    Am J Cardiol; 1987 May; 59(14):61G-67G. PubMed ID: 2884854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension.
    Houston MC; Burger C; Hays JT; Nadeau J; Swift L; Bradley CA; Olafsson L
    Am Heart J; 1990 Jul; 120(1):172-9. PubMed ID: 2193493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of two antihypertensive agents on lipids, lipoproteins, and apoproteins A and B. Comparison of prazosin and atenolol.
    Rouffy J; Jaillard J
    Am J Med; 1986 Feb; 80(2A):100-3. PubMed ID: 3511689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre, hospital study of the efficacy and safety of terazosin and its effects on the plasma cholesterol levels of patients with essential hypertension.
    Lytle TB; Coles SJ; Waite MA
    J Clin Pharm Ther; 1991 Aug; 16(4):263-73. PubMed ID: 1682328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses, and postprandial lipemia.
    Superko HR; Wood PD; Krauss RM
    Am J Med; 1989 Jan; 86(1B):26-31. PubMed ID: 2913769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ
    Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of terazosin and enalapril on laboratory stress testing blood pressure in patients with essential hypertension.
    Cardillo C; Degen C; Campia U; De Felice F; Folli G
    J Clin Pharmacol; 1993 May; 33(5):433-8. PubMed ID: 8101194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxazosin versus atenolol: a randomized comparison of calculated coronary heart disease risk reduction.
    Mazzola C; Guerrasio E
    Am Heart J; 1988 Dec; 116(6 Pt 2):1797-801. PubMed ID: 2904753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients.
    Rouffy J; Jaillard J
    Am J Med; 1984 Feb; 76(2A):105-8. PubMed ID: 6702861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG
    Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.